MINI FUTURE LONG - MEDTRONIC Share Price

Certificat

DE000BP8Q2J1

Real-time Bid/Ask 03:21:54 01/07/2024 pm IST
4.3 EUR / 4.4 EUR +1.16% Intraday chart for MINI FUTURE LONG - MEDTRONIC
Current month-2.05%
1 month-5.91%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/24/01 4.3 0.00%
28/24/28 4.3 -1.60%
27/24/27 4.37 -1.13%
26/24/26 4.42 -0.90%
25/24/25 4.46 -1.33%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 11:36 am IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN BP8Q2J
ISINDE000BP8Q2J1
Date issued 25/04/2013
Strike 32.62 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.89
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.51
Lowest since issue 0.87
Spread 0.1
Spread %2.27%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus